文献速递心脑血管急症

光学相干断层扫描指导与血管造影指导的经皮冠状动脉介入治疗对比

Optical Coherence Tomography-Guided versus Angiography-Guided PCI.
PubMed 文献 · N Engl J Med · 2023-08-27
一句话结论在需PCI的患者中,OCT指导较血管造影指导获得更大的最小支架面积(5.72 vs 5.36 mm²),但2年靶血管失败率无显著差异(7.4% vs 8.2%,HR 0.90,95%CI 0.67-1.19,P=0.45)。

该前瞻性、随机、单盲试验在18个国家80个中心纳入2487例药物治疗的糖尿病患者或复杂冠状动脉病变患者,随机接受OCT指导PCI(1233例)或血管造影指导PCI(1254例)。主要疗效终点之一为PCI后OCT评估的最小支架面积,OCT组为5.72±2.04 mm²,血管造影组为5.36±1.87 mm²(均差0.36 mm²,95%CI 0.21-0.51,P<0.001)。2年靶血管失败(心源性死亡、靶血管心肌梗死或缺血驱动的靶血管血运重建复合终点)OCT组88例(Kaplan-Meier估计7.4%),血管造影组99例(8.2%)(HR 0.90,95%CI 0.67-1.19,P=0.45)。OCT相关不良事件OCT组1例,血管造影组2例;2年支架血栓OCT组6例(0.5%),血管造影组17例(1.4%)。

要点

  • OCT指导PCI后最小支架面积大于血管造影指导(5.72±2.04 mm² vs 5.36±1.87 mm²,均差0.36 mm²,95%CI 0.21-0.51,P<0.001)。
  • 2年靶血管失败率OCT组7.4% vs 血管造影组8.2%(HR 0.90,95%CI 0.67-1.19,P=0.45),无显著差异。
  • 2年支架血栓OCT组6例(0.5%)vs 血管造影组17例(1.4%)。
  • OCT相关不良事件OCT组1例 vs 血管造影组2例。
  • 研究纳入药物治疗的糖尿病患者或复杂冠状动脉病变患者,OCT组1233例,血管造影组1254例。

适用人群与场景

  • 药物治疗的糖尿病患者或复杂冠状动脉病变患者,接受PCI。

研究设计与关键结果

  • 前瞻性、随机、单盲试验,在18个国家80个中心纳入2487例患者,随机分为OCT指导PCI组(1233例)和血管造影指导PCI组(1254例)。
  • 主要疗效终点之一:PCI后OCT评估的最小支架面积,OCT组5.72±2.04 mm² vs 血管造影组5.36±1.87 mm²(均差0.36 mm²,95%CI 0.21-0.51,P<0.001)。
  • 主要疗效终点之二:2年靶血管失败(心源性死亡、靶血管心肌梗死或缺血驱动的靶血管血运重建复合终点),OCT组88例(Kaplan-Meier估计7.4%)vs 血管造影组99例(8.2%)(HR 0.90,95%CI 0.67-1.19,P=0.45)。
  • 安全性:OCT相关不良事件OCT组1例 vs 血管造影组2例;2年支架血栓OCT组6例(0.5%)vs 血管造影组17例(1.4%)。

证据类型、等级与局限

  • 证据类型:前瞻性、随机、单盲试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:在接受PCI的患者中,OCT指导较血管造影指导获得更大的最小支架面积,但2年靶血管失败率无显著组间差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Data regarding clinical outcomes after optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) as compared with angiography-guided PCI are limited.

METHODS: In this prospective, randomized, single-blind trial, we randomly assigned patients with medication-treated diabetes or complex coronary-artery lesions to undergo OCT-guided PCI or angiography-guided PCI. A final blinded OCT procedure was performed in patients in the angiography group. The two primary efficacy end points were the minimum stent area after PCI as assessed with OCT and target-vessel failure at 2 years, defined as a composite of death from cardiac causes, target-vessel myocardial infarction, or ischemia-driven target-vessel revascularization. Safety was also assessed.

RESULTS: The trial was conducted at 80 sites in 18 countries. A total of 2487 patients underwent randomization: 1233 patients were assigned to undergo OCT-guided PCI, and 1254 to undergo angiography-guided PCI. The minimum stent area after PCI was 5.72±2.04 mm2 in the OCT group and 5.36±1.87 mm2 in the angiography group (mean difference, 0.36 mm2; 95% confidence interval [CI], 0.21 to 0.51; P<0.001). Target-vessel failure within 2 years occurred in 88 patients in the OCT group and in 99 patients in the angiography group (Kaplan-Meier estimates, 7.4% and 8.2%, respectively; hazard ratio, 0.90; 95% CI, 0.67 to 1.19; P = 0.45). OCT-related adverse events occurred in 1 patient in the OCT group and in 2 patients in the angiography group. Stent thrombosis within 2 years occurred in 6 patients (0.5%) in the OCT group and in 17 patients (1.4%) in the angiography group.

CONCLUSIONS: Among patients undergoing PCI, OCT guidance resulted in a larger minimum stent area than angiography guidance, but there was no apparent between-group difference in the percentage of patients with target-vessel failure at 2 years. (Funded by Abbott; ILUMIEN IV: OPTIMAL PCI ClinicalTrials.gov number, NCT03507777.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Ali ZA, Landmesser U, Maehara A, et al. Optical Coherence Tomography-Guided versus Angiography-Guided PCI. N Engl J Med. 2023. PMID: 37634188. doi:10.1056/NEJMoa2305861

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。